Core Insights - Edgewell Personal Care (EPC) reported a quarterly loss of $0.16 per share, which was better than the Zacks Consensus Estimate of a loss of $0.18, representing an earnings surprise of +11.11% [1] - The company posted revenues of $422.8 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 12.15% and down from $478.4 million year-over-year [2] - The stock has increased by approximately 21.7% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.71 on revenues of $588.06 million, while for the current fiscal year, the estimate is $2.33 on revenues of $2.26 billion [7] - The estimate revisions trend for Edgewell Personal was unfavorable prior to the earnings release, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Consumer Products - Staples industry, to which Edgewell belongs, is currently in the bottom 30% of the Zacks Industry Rank, suggesting that stocks in this category may underperform compared to those in the top 50% [8]

Group 1: Company Overview - Kodiak Gas Services (KGS) shares increased by 11.6% to close at $47.31, with a notable trading volume compared to normal sessions, and an 18% gain over the past four weeks [1][2] - The company announced a $690 million acquisition of Distributed Power Solutions (DPS), which provides reliable distributed power solutions, marking a strategic expansion beyond its core natural gas compression business [2] Group 2: Acquisition Details - The acquisition of DPS adds 384 MW of power generation assets, including Caterpillar engines and turbines, enhancing Kodiak's operational capabilities and reliability [2] - This strategic move positions Kodiak to tap into high-growth markets such as data centers, which are experiencing rapidly rising power demand, thus supporting more stable and contracted cash flows [2] Group 3: Financial Performance Expectations - Kodiak Gas is expected to report quarterly earnings of $0.67 per share, reflecting a year-over-year increase of 148.2%, with revenues projected at $334.77 million, up 8.2% from the previous year [3] - The consensus EPS estimate for the quarter has been revised 1% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Group 4: Industry Context - Kodiak Gas operates within the Zacks Oil and Gas - Mechanical and Equipment industry, which includes other companies like Natural Gas Services (NGS), that recently closed at $34.77, up 0.6% [5] - NGS has a consensus EPS estimate of $0.37 for the upcoming report, representing a year-over-year change of 27.6%, and also holds a Zacks Rank of 3 (Hold) [6]

Group 1 - Huron Consulting (HURN) shares increased by 4% to close at $172.15, supported by strong trading volume, contrasting with a 7.7% decline over the past four weeks [1] - The stock's positive performance is attributed to capital returns through share buybacks and the expansion of service offerings, including acquisitions, which enhance long-term growth visibility [1] - The upcoming quarterly earnings are expected to be $1.94 per share, reflecting a year-over-year increase of 2.1%, with revenues projected at $432.95 million, up 11.5% from the previous year [2] Group 2 - The consensus EPS estimate for Huron Consulting has remained stable over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] - Huron Consulting holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [3] - In comparison, CBIZ (CBZ), another company in the consulting services industry, saw a 1.9% increase in its stock price, closing at $38.21, despite a significant decline of 29.3% over the past month [3]

Core Viewpoint - Digital Turbine (APPS) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on an upward trend in earnings estimates, which significantly influences stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the correlation between changes in earnings estimates and stock price movements, making it a valuable tool for investors [2][3]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to stock price fluctuations based on their buying or selling actions [3]. Business Improvement Indicators - The upgrade in earnings estimates for Digital Turbine suggests an improvement in the company's underlying business, which could lead to higher stock prices as investors respond positively [4]. Importance of Earnings Estimate Revisions - Research indicates a strong correlation between earnings estimate revisions and short-term stock movements, highlighting the significance of tracking these revisions for investment decisions [5]. - The Zacks Rank system effectively utilizes earnings estimate revisions to classify stocks, providing a structured approach to investment [6]. Specific Earnings Estimates for Digital Turbine - For the fiscal year ending March 2026, Digital Turbine is projected to earn $0.36 per share, consistent with the previous year's figure, while the Zacks Consensus Estimate has increased by 162.5% over the past three months [7]. Zacks Rating System Overview - The Zacks rating system maintains a balanced distribution of ratings, with only the top 5% of stocks receiving a "Strong Buy" rating, indicating superior earnings estimate revisions [8][9]. - Digital Turbine's upgrade to Zacks Rank 1 places it among the top 5% of stocks covered by Zacks, suggesting potential for market-beating returns in the near term [9].

分组1 - Philip Morris reported quarterly earnings of $1.7 per share, exceeding the Zacks Consensus Estimate of $1.67 per share, and showing an increase from $1.55 per share a year ago, resulting in an earnings surprise of +2.04% [1] - The company posted revenues of $10.36 billion for the quarter ended December 2025, which was 0.63% below the Zacks Consensus Estimate, but an increase from $9.71 billion year-over-year [2] - Philip Morris has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates twice during the same period [2] 分组2 - The stock has increased approximately 13.5% since the beginning of the year, while the S&P 500 has declined by 0.7% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for future stock performance [4] - The current consensus EPS estimate for the upcoming quarter is $1.88 on revenues of $10.15 billion, and for the current fiscal year, it is $8.34 on revenues of $44.09 billion [7] 分组3 - The Zacks Industry Rank indicates that the Tobacco industry is currently in the bottom 36% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Turning Point Brands, another company in the Tobacco industry, is expected to report quarterly earnings of $0.87 per share, reflecting a year-over-year increase of +64.2% [9]

分组1 - Roivant Sciences Ltd. reported a quarterly loss of $0.24 per share, better than the Zacks Consensus Estimate of a loss of $0.27, representing an earnings surprise of +9.43% [1] - The company has surpassed consensus EPS estimates two times over the last four quarters [2] - Montes Archimedes Acquisition posted revenues of $2 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 67.32%, compared to year-ago revenues of $9.02 million [2] 分组2 - The stock of Montes Archimedes Acquisition has lost about 2.6% since the beginning of the year, while the S&P 500 has declined by 0.7% [3] - The earnings outlook for Montes Archimedes Acquisition is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters [4] - The estimate revisions trend for Montes Archimedes Acquisition was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock [6] 分组3 - The current consensus EPS estimate for the coming quarter is -$0.28 on $7.3 million in revenues, and -$1.13 on $19.19 million in revenues for the current fiscal year [7] - The Medical - Biomedical and Genetics industry is currently in the top 37% of the Zacks industries, indicating a favorable outlook for stocks in this sector [8] - TScan Therapeutics, Inc., another company in the same industry, is expected to report a quarterly loss of $0.27 per share, with revenues projected to be $4.08 million, up 509% from the year-ago quarter [9]

Company Performance - Strategy reported a quarterly loss of $42.93 per share, which was better than the Zacks Consensus Estimate of $46.02, compared to a loss of $3.2 per share a year ago, indicating an earnings surprise of -193.29% [1] - The company posted revenues of $122.99 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.83%, and showing an increase from year-ago revenues of $120.7 million [2] - Over the last four quarters, Strategy has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Strategy shares have lost about 15% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current Zacks Rank for Strategy is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $5.81 on revenues of $119.9 million, and for the current fiscal year, it is $51.60 on revenues of $496.05 million [7] - The estimate revisions trend for Strategy was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Financial - Miscellaneous Services industry, to which Strategy belongs, is currently in the top 33% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Strategy's performance [5]

Core Insights - MGM Resorts reported quarterly earnings of $1.6 per share, significantly exceeding the Zacks Consensus Estimate of $0.64 per share, and up from $0.45 per share a year ago, representing an earnings surprise of +151.14% [1] - The company generated revenues of $4.61 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.63% and increasing from $4.35 billion year-over-year [2] Earnings Performance - Over the last four quarters, MGM has surpassed consensus EPS estimates three times and topped revenue estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is $0.72, with expected revenues of $4.37 billion, while the estimate for the current fiscal year is $2.11 on revenues of $17.66 billion [7] Market Position and Outlook - MGM shares have increased by approximately 1.2% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] - The Zacks Rank for MGM is currently 4 (Sell), indicating expectations of underperformance in the near future due to unfavorable estimate revisions prior to the earnings release [6] Industry Context - The Gaming industry, to which MGM belongs, is currently ranked in the bottom 24% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of MGM's stock may be influenced by the overall outlook for the industry, as historical data shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

分组1 - Illumina reported quarterly earnings of $1.35 per share, exceeding the Zacks Consensus Estimate of $1.26 per share, and showing an increase from $0.86 per share a year ago, resulting in an earnings surprise of +7.42% [1] - The company achieved revenues of $1.16 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.35% and increasing from $1.1 billion year-over-year [2] - Illumina has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has gained approximately 2.3% since the beginning of the year, outperforming the S&P 500, which has gained 0.5% [3] - The future performance of Illumina's stock will depend on management's commentary during the earnings call and the earnings outlook for upcoming quarters [4][6] - The current consensus EPS estimate for the next quarter is $1.11 on revenues of $1.07 billion, and for the current fiscal year, it is $5.08 on revenues of $4.44 billion [7] 分组3 - The Medical - Biomedical and Genetics industry, to which Illumina belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook for the sector [8] - The correlation between near-term stock movements and earnings estimate revisions is strong, indicating that tracking these revisions can be beneficial for investors [5]

分组1 - Envista reported quarterly earnings of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, and up from $0.24 per share a year ago, representing an earnings surprise of +18.23% [1] - The company achieved revenues of $750.6 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 11.16%, compared to $652.9 million in the same quarter last year [2] - Envista has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 9% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is $0.27 on revenues of $651.12 million, and for the current fiscal year, it is $1.26 on revenues of $2.74 billion [7] - The Medical - Products industry, to which Envista belongs, is currently ranked in the bottom 29% of over 250 Zacks industries, indicating potential challenges ahead [8]